Optic Nerve Amyloid Deposition Disguised as Optic Nerve Sheath Meningioma.


Journal

Ophthalmic plastic and reconstructive surgery
ISSN: 1537-2677
Titre abrégé: Ophthalmic Plast Reconstr Surg
Pays: United States
ID NLM: 8508431

Informations de publication

Date de publication:
13 Aug 2024
Historique:
medline: 13 8 2024
pubmed: 13 8 2024
entrez: 13 8 2024
Statut: aheadofprint

Résumé

Localized orbital amyloidosis is a rare clinical entity. Periocular and orbital amyloid deposits are mainly located at the lacrimal apparatus, eyelid, conjunctiva, ocular adnexa, extraocular muscles, and levator palpebrae muscle. In this article, we report an unusual case of optic nerve amyloid deposition in an 82-year-old African American woman who presented with vertical diplopia. MRI revealed an enhancing mass from the optic nerve sheath, and CT showed foci of calcifications suggestive of optic nerve meningioma. However, an incisional biopsy demonstrated lymphoproliferative disease with focal optic nerve sheath amyloid deposition confirmed by histologic Congo red staining and immunohistochemistry.

Identifiants

pubmed: 39136965
doi: 10.1097/IOP.0000000000002720
pii: 00002341-990000000-00442
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The American Society of Ophthalmic Plastic and Reconstructive Surgery, Inc.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to disclose.

Références

Jamshidi P, Levi J, Suarez MJ, et al. Clinicopathologic and proteomic analysis of amyloidomas involving the ocular surface and adnexa. Am J Clin Pathol 2022;157:620–627.
Al-Nuaimi D, Bhatt PR, Steeples L, et al. Amyloidosis of the orbit and adnexae. Orbit 2012;31:287–298.
Aryasit O, Preechawai P, Kayasut K. Clinical presentation, treatment, and prognosis of periocular and orbital amyloidosis in a university-based referral center. Clin Ophthalmol 2013;7:801–805.
Mora-Horna ER, Rojas-Padilla R, López VG, et al. Ocular adnexal and orbital amyloidosis: a case series and literature review. Int Ophthalmol 2016;36:281–298.
Tong JY, Juniat V, McKelvie PA, et al. Clinical and radiological features of intramuscular orbital amyloidosis: a case series and literature review. Ophthalmic Plast Reconstr Surg 2022;38:234–241.
Marcet MM, Roh JH, Mandeville JT, et al. Localized orbital amyloidosis involving the lacrimal sac and nasolacrimal duct. Ophthalmology 2006;113:153–156.
Evans W, Thompson B, Dryden SC, et al. Primary isolated lacrimal gland amyloidosis: a case report and review of the literature. Cureus 2019;11:e6258.
Singla K, Sen M, Milman T, et al. Conjunctival amyloidosis: apples and oranges. Ophthalmic Plast Reconstr Surg 2022;39:e98–e98.
Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet 2016;387:2641–2654.
Gean-Marton AD, Kirsch CF, Vezina LG, et al. Focal amyloidosis of the head and neck: evaluation with CT and MR imaging. Radiology 1991;181:521–525.
Taban M, Piva A, See RF, et al. Review: orbital amyloidosis. Ophthalmic Plast Reconstr Surg 2004;20:162–165.
Oishi A, Miyamoto K, Yoshimura N. Orbital amyloidosis–induced compressive optic neuropathy accompanied by characteristic eyelid pigmentation. Ophthalmic Plast Reconstr Surg 2006;22:485–487.
Reynolds MM, Veverka KK, Gertz MA, et al. Ocular manifestations of systemic amyloidosis. Retina 2018;38:1371–1376.
Bennassi A, Kinj R, Chaabouni S, et al. Orbital amyloidosis and radiotherapy: a case report and review of literature. Cancer Radiother 2022;26:1070–1074.
Lawton AW, Leone CR Jr., Hunter DM. Optic nerve pseudomeningioma secondary to localized amyloidosis. Ophthalmic Plast Reconstr Surg 1989;5:52–55.
Leibovitch I, Selva D, Goldberg RA, et al. Periocular and orbital amyloidosis: clinical characteristics, management, and outcome. Ophthalmology 2006;113:1657–1664.
Banerjee P, Alam MS, Subramanian N, et al. Orbital and adnexal amyloidosis: thirty years experience at a tertiary eye care center. Indian J Ophthalmol 2021;69:1161–1166.
Dammacco R, Merlini G, Lisch W, et al. Amyloidosis and ocular involvement: an overview. Semin Ophthalmol 2020;35:7–26.
Fraunfelder FW. Liquid nitrogen cryotherapy for conjunctival amyloidosis. Arch Ophthalmol 2009;127:645–648.
Khaira M, Mutamba A, Meligonis G, et al. The use of radiotherapy for the treatment of localized orbital amyloidosis. Orbit 2008;27:432–437.
Pasternak S, White VA, Gascoyne RD, et al. Monoclonal origin of localised orbital amyloidosis detected by molecular analysis. Br J Ophthalmol 1996;80:1013–1017.
Martel A, Oberic A, Moulin A, et al. Caractéristiques cliniques, radiologiques, anatomopathologiques, thérapeutiques et évolutives de l’amylose périoculaire et/ou intraorbitaire: à propos de 6 cas et revue de la littérature. J Fr d’Ophtalmol 2018;41:492–506.
Banerjee S, Bogman J, Reuser TTQ. Amyloid deposition in the extraocular muscles. Orbit 1999;18:105–106.
Chean CS, Sovani V, Boden A, et al. Lacrimal gland extranodal marginal zone B-cell lymphoma in the presence of amyloidosis. Orbit 2022;41:350–353.

Auteurs

Niloufar Bineshfar (N)

Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, U.S.A.

Classifications MeSH